MiroDX is a healthcare solutions startup focused on population health surveillance -- initially for COVID-19. R&D efforts include working with partners to bring the next generation of remote sample collection lab tests to a global market, with the aim of increasing access and managing costs for improved patient care. Together, the founding partners of MiroDx bring experience as C-suite executives at the world's largest health systems, experts in lab & mass spectrometry, healthcare entrepreneurs, and healthcare legal experts, resulting in extensive knowledge required to accurately identify and quantify market opportunity.